Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells

Cell Death and Differentiation

Volumn 7, Issue 4, 2000, Pages 384-392

  Hoetelmans, R W M ^a   Van Slooten, H J ^a   Keijzer, R ^a   Erkeland, S ^a   Van De Velde, C J H ^a   Van Dierendonck, J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bax; Bcl 2; Cell fractionation; Cellular nucleus; Confocal immunofluorescence microscopy; Mitotic chromosomes

Indexed keywords

ANTIBODY; EPITOPE; NUCLEAR PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ARTICLE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL NUCLEUS; CHROMATIN; COLON CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERPHASE; MAMMAL CELL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; WESTERN BLOTTING;

ANIMALIA; MAMMALIA;

EID: 0034119019     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400664     Document Type: Article

References (53)

1. Adams JM and Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
2. Reed JC (1998) Bcl-2 family proteins. Oncogene 17: 3225-3236
3. Tsujimoto Y, Finger LR, Yunis J, Nowell PC and Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-1099
4. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsrneyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336
5. Oltvai N, Milliman CL and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
6. Knudson CM and Korsmeyer SJ (1997) Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16: 358-363
7. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton Wand Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53: 4701-4714
8. Alnemri ES, Robertson NM, Fernandes TF, Croce CM and Litwack G (1992) Overexpressed full-length human Bcl-2 extends the survival of baculovirus-infected Sf9 insect cells. Proc. Natl. Acad. Sci. USA 89: 7295-7299
9. Monaghan P, Robertson D, Amos TA, Dyer MJ, Mason DY and Greaves MF (1992) Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem 40: 1819-1825
10. Akao Y, Otsuk Y, Kataoka S, Ito Y and Tsujimoto Y (1994) Muliple subcellular localization of Bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 54: 2468-2471
11. Givol I, Tsarfaty I, Rulong S, Pinto daSilva P, Nasioulas G DuHadaway J, Hughes SH and Evert DL (1994) Bcl-2 expressed using a retroviral vector is localized primarily in the nuclear membrane and the endoplasmic reticulum of chicken embryo fibroblasts. Cell Growth Diff. 5:419-429
12. DeJong D, Prins FA, Mason DY, Reed JC, VanOmmen GB and Kluin PM (1994) Subcellular localization of the Bcl-2 protein in malignant and normal lymphoid cells. Cancer Res. 54: 256-260
13. Jacobson MD, Burne JF, King MP, MiyashitaT, Reed JC and Raff MC (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369
14. Chen-Levy Z, Nourse J and Cleary ML (1989) The bcl-2 candidate protooncogene product is a 24 kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell Biol. 9:701-710
15. Nguyen M, Millar DG, Yong WV, Korsmeyer J and Shore GC (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268:25265-25268
16. Borner C, Martinou I, Mattmann C, Irmler M, Schaerer E, Martinou J-C and Tschopp J (1994) The protein Bcl-2 does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol. 126: 1059-1068
17. Tanaka S, Saito K and Reed JC (1993) Structure-function analysis of the Bcl-2 oncoprotein. J. Biol. Chem. 268: 10920-10926
18. Zhu W, Cowie A, Wasfy GW, Penn LZ, Leber B and Andrews DW (1996) Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15: 4130-4141
19. Bruel A, Karsenty E, Schmid M, McDonnell TJ and Lanotte M (1997) Altered sensitivity to retinoid-induced apoptosis associated with change in the subcellular distribution of Bcl-2. Exp. Cell Res. 233: 281-287
20. Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi X-G and Youle RJ. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139: 1281-1292
21. Gross A, Jockel J, Wei MC and Korsmeyer J (1998) Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17: 3878-3885
22. Goping IS, Gross A, Lavoie JN, Jemmerson R, Roth K, Korsmeyer SJ and Shore GC (1998) Regulated targeting of Bax to mitochondria. J. Cell Biol. 143: 207-215
23. Mandai M, Adam L, Mendelsohn J and Kumar R (1998) Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Oncogene 17: 999-1007
24. Nishita M, Inoue S, Tsuda M, Tateda C and Miyashita T (1998) Nuclear translocation and increased expression of Bax and disturbance in cell cycle progression without prominent apoptosis induced by hyperthermia. Exp. Cell Res. 244: 357-366
25. Ho YS, Lee HM, Chang CR and Lin JK (1999) Induction of Bax protein and degradation of Iamin A during p53-dependent apoptosis induced by chemotherapeutic agents in human cancer cell lines. Biochem. Pharmacol. 57: 143-154
26. L1 an inhibitor of programmed cell death. Nature 381: 335-341
27. Schlesinger PH, Gross A, Yin XM, Yamamoto K, Saito M, Waksman G and Korsmeyer SJ (1997) Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94: 11357-11362
28. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod J-J, Mazzei G, Maudrell K, Gambale F, Sadoulk R and Martinou J-C (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372
29. Van Slooten HJ, Clahsen PC, Van Dierendonck JH, Duval CH, Pallud C, Mandard A-M, Delobelle-Deroide A, VandeVelde CHJ and VandeVijver MJ (1996) Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br. J. Cancer 74: 78-85
30. Lu QL, Hanby AM, Hajibagheri MAN, Gschmeissner SE, Lu P-J, Taylor-Papadimitriou JT, Krajewski S, Reed JC and Wright NA (1994) Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell Sci. 107: 363-371
31. Willingham MC and Bhalla KJ (1994) Transient mitotic phase localization of Bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J. Histochem. Cytochem. 42: 441-450
32. Chan WK, Mole MM, Levison DA, Ball RY, Lu Q-L, Patel K and Hanby AM (1995) Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma. Am. J. Pathol. 177: 241-246
33. Paraf F, Gogusev J, Chrétien Y and Droz D (1995) Expression of bcl-2 oncoprotein in renal cell tumours. J. Pathol. 177: 247-252
34. Drachenberg CB, loffe OB, Castellani RJ and Papadimitriou JC (1997) Nuclear Bcl-2 staining in tumors [letter]. Am. J. Clin. Pathol. 108: 479
35. Schandle CA, Li S, Re GG, Fan W and Willingham MC (1999) Mitotic chromosomal Bcl-2: I. Stable expression throughout the cell cycle and association with isolated chromosomes. J. Histochem. Cytochem. 47: 139-149
36. Schandle CA, Li S, Re GG, Fan W and Willingham MC (1999) Mitotic chromosomal Bcl-2: II. Localization to interphase nuclei. J. Histochem. Cytochem. 47: 151-158
37. Teixeira C, Reed JC and Pratt MAC (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:3902-3907
38. Graham JM and Higgins JA (1993) Methods in Molecular Biology, Volume 19: Biomembrane protocols: I. Isolation and analysis
39. Manilal S, Nguyen TM and Morris GE (1998) Colocalization of emerin and lamins in interphase nuclei and changes during mitosis. Biochem. Biophys. Res. Commun. 249: 643-647
40. Melan M and Sluder G (1992) Redistribution and differential extraction of soluble proteins in permeabilized cultured cells. J. Cell Science 101: 731-743
41. Ling Y-H, Tornos C and Perez-Sloer R (1998) Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J. Biol.Chem. 273: 18984-18991
42. Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD and Pietenpol JA (1998) Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and taxol-induced growth arrest. J. Biol. Chem. 273: 30777-30784
43. Papadimitriou JC, Ioffe OB, Castellani RJ, Ord RA, Simons J and Drachtenberg CB (1996) Shifting of cytoplasmic pattern of bcl-2 expression in reactive and preneoplastic lesions to nuclear pattern in their malignant counterparts. Cancer Detect. Prev. 2: 529-530A
44. Quignon F, DeBels F, Koken M, Feunteun J, Ameisen J-C and deThé H (1998) PML induces a novel caspase-independent death process. Nat. Genet. 20: 259-265
45. Quignon F, DeBels F, Koken M, Feunteun J, Ameisen J-C and deThé H (1999) Published erratum in Nat. Genet. 22: 115
46. Rao L, Modha D and White E (1997) The E1B19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene 15: 1587-1597
47. Van Slooten H-J, Van de Vijver MJ, Van de Velde CJH and Van Dierendonck JH (1998) Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br. J. Cancer 77: 789-796
48. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW and Vogelstein B (1994) Paradoxical inhibition of solid tumor cell growth by Bcl-2. Cancer Res. 54: 3714-3717
49. Huang DCS, O'Reilly LA, Strasser A and Cory S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from an inhibitory effect on cell cycle entry. EMBO J. 16: 4628-4638
50. Gil-Gömez G, Berns A and Brady HJM (1998) A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17: 7209-7218
51. Takayama S, Xie Z and Reed JC (1999) An evolutionary conserved family of Hsp70/Hsc70 molecularchaperone regulators. J. Biol. Chem. 274: 781-786
52. Wang J, Moreira KM, Campos B, Kaetzel MA and Dedman JR (1996) Targeted neutralization of calmodulin in the nucleus blocks DNA synthesis and cell cycle progression. Biochim. Biophys. Acta 1313: 223-228
53. Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol. 13: 29-83